Showing results (11-20 of 476) with videos related to
Sort By:
Pageof 48
Cancer Treatment Reviews|March 1, 1991
The role of hexamethylmelamine in the management of ovarian cancerP S Schein, B Scheffler, W McCullochCancer Research|May 1, 1982
Doxorubicin-induced chronic cardiotoxicity and its protection by liposomal administrationA Rahman, N More, P S ScheinCancer|December 1, 1975
Chemotherapy of large intestinal carcinoma. Current results and future prospectsP S Schein, D Kisner, J S MacDonaldCancer Research|January 1, 1978
A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranoseR A Nagourney, P Fox, P S ScheinCancer Investigation|January 1, 1991
New protective agents for bone marrow in cancer therapyW McCulloch, B J Scheffler, P S ScheinCancer Research|May 1, 1986
Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in miceJ E Cantrell, D Green, P S ScheinRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Preclinical and clinical studies on chlorozotocin, a new nitrosourea with decreased bone marrow toxicityJ S Macdonald, D Hoth, P S ScheinCancer Research|March 1, 1975
Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicityT Anderson, M G McMenamin, P S ScheinThe Journal of Clinical Investigation|October 1, 1979
Chlorozotocin. Mechanism of reduced bone marrow toxicity in miceL C Panasci, D Green, P S ScheinPageof 48